... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Chemotherapy Thrombosis Thrombin...

... enzymatic (genesis of metalloproteinase) phenomenon of plaque disruption is evolving. 3) Thrombosis: we have shown that monocytes/macrophages in lipid-rich plaques may play a detrimental role after plaque disruption, promoting thrombin generation and thrombosis through the tissue factor pathway that can...

.... ADAMTS13 Thrombosis Endothelial cells von Willebrand factor Original Paper Pathophysiol Haemost Thromb 2007 08;36:233 240 DOI: 10.1159/000252818 Received: March 31, 2009 Accepted after revision: August 24, 2009 Regulation of ADAMTS13 Expression in Proliferating Human Umbilical Vein Endothelial Cells...

... in a jugular vein thrombus model in rabbits utilizing a combination of endothelial damage and flow reduction. The parameters observed were the frequency of visible thrombosis, the frequency of occlusive thrombosis and thrombus weights. DS and r-hirudin were investigated in one fixed dose and the LMWHs...

...William A. Bower; John E. Humphries A 34-year-old man with recurrent deep and superficial thromboses was found to have severe protein S deficiency. Treatment with both warfarin and adjusted-dose subcutaneous heparin failed to completely prevent thrombosis. Based on reports of increases...

... referred for deep vein thrombosis, 3 had history of deep vein thrombosis, 1 had both arterial thrombosis and a history of venous thrombosis; 2 had thrombocytopenia; 3 had stroke, 1 had a history of s troke. One patient had SLE according to ARA classification. The most frequent associated disease was cancer...

...Maria Benedetta Donati Thrombosis is the most frequent complication and the second cause of death in patients with overt malignant disease. Increasing evidence suggests that thrombotic episodes may also precede the diagnosis of cancer by months or years thus representing a potential marker...

... was the incidence of proximal deep-vein thrombosis or pulmonary embolism. Patients were assessed during the study period for development of proximal deep-vein thrombosis by compression sonography at days 1 and 10 and for pulmonary embolism by scintigraphy in symptomatic patients. Aim of the study was to demonstrate...

...Alberto Cogo; Anthonie W.A. Lensing; Phil Wells; Paolo Prandoni; Harry R. Büller Deep-vein thrombosis of the lower extremity is a frequent disorder associated with morbidity and mortality due to pulmonary embolism and the postthrombotic syndrome. It was not until the introduction of contrast...

..., but not collagen- or thrombin-induced platelet aggregation. Thrombosis Platelet Ticlopidine Laser Rat Original Paper Haemostasis 1992;22:147-152 J. Yamamoto I. Ishii Y. Sasaki Y. Nagamatsu T. Matsuda E. Ando Laboratory of Physiology, Faculty of Nutrition, Kobe-Gakuin University, Kobe, Japan...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Warfarin Necrosis Thrombosis 2 07 1991 4 10 1991 28 4 2009 Original Paper Haemostasis 1992;22:124...

... from any ideas, methods, instructions or products referred to in the content or advertisements. von Willebrand disease Hemostasis Thrombosis Bleeding Coagulation defect Haemostasis 1994;24:265-275 Zaverio M. Ruggeri Roon Research Center for Arteriosclerosis and Thrombosis, Departments...

...Abdul Kareem M. Al-Momen; Sameer O. Huraib Four hemodialysis patients (1 male and 3 females, aged 29-40 years) with unusual recurrent vascular access or dialyzer thrombosis were studied to find out whether a hypercoagulable state exists. Measurements of euglobulin clot lysis time (ELT), fibrinogen...

... μM). The results show that KRDS is an inhibitor for platelet aggregation and secretion to which the inhibition is more potent. Meanwhile, in the experiment of arterial thrombosis in dogs, KRDS (5 μ M /kg) and 125 I-SZ-51 (a monoclonal antibody against GMP-140) were injected before operation...

.... Thrombosis Platelet aggregation Laser Exercise Microvessels Original Paper Haemostasis 1993;23:129-134 J. Yamamotoa I. Ishiia A. Chikamoria Y. Sasakia Y. Nagamatsua 5. Morita0 M. Tsukaharab Laboratory of Physiology, Faculty of Nutrition, and Faculty of Humanities and Sciences, Kobe-Gakuin University...

...) were observed between factor V and protein C, fibrinogen and protein C, factor V and antithrombin III and protein C and antithrombin III. Four cancer patients had a history of thromboembolism; their aPC-SR was similar to that of patients without thrombosis. Of the several coagulation measures examined...

... surgery (mean age 18 years). Our data suggest a similar evolution of C4BP isoforms in all these patients, with an almost exclusive increase of C4BP isoforms lacking C4BPΒ polypeptides and steady levels of free protein S. Acute phase response C4b-binding protein Protein S Surgery Thrombosis...

...Charles Marc Samama; Sophie Combe; Patrick Ill; Eric Barre; Sophie Dreux; Pierre Viars The pharmacologic specificity of low-molecular-weight heparins (LMWHs) has enabled multiple attractive developments in the prophylaxis and treatment of arterial thrombosis. Their high antithrombotic potency...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Oral anticoagulants Warfarin Coronary artery disease Thrombosis Myocardial infarction Unstable angina Clinical trials Primary prevention...

...Lars C. Borris; Michael R. Lassen Venography is the key diagnostic method of screening for deep venous thrombosis in clinical prophylaxis studies. Although the venographic technique is standardized the outcome is subject to variation for several reasons. The different methodological pitfalls...